Crizac appoints Nagle as Chairperson, Vikash Agarwal steps down from role
Crizac Limited has undergone a major board reshuffle with Christopher Flood Nagle appointed as Chairperson and Additional Director, replacing Dr. Vikash Agarwal who retains his Managing Director role. Ms. Pinky Agarwal resigns from the Board, leading to committee reconstitutions. Independent Directors Anuj Saraswat and Payal Bafna are up for re-appointment for three-year terms starting in 2027.

*this image is generated using AI for illustrative purposes only.
crizac has executed a significant restructuring of its Board of Directors, appointing Christopher Flood Nagle as Additional Non-Executive Director and Chairperson effective August 3 and August 4, 2026, respectively. Concurrently, Dr. Vikash Agarwal has relinquished the position of Chairperson to devote greater attention to his role as Managing Director, and Ms. Pinky Agarwal has resigned from the Board due to other professional commitments. These changes centralize governance under Nagle, who recently stepped down as CEO of the UK subsidiary, while maintaining operational continuity through Agarwal’s continued executive leadership.
The appointments and resignations were approved by the Board at its meeting held on August 3, 2026, pursuant to the recommendation of the Nomination & Remuneration Committee. The disclosures were made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III and SEBI Master Circular no. HO/49/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Nagle’s transition marks a shift from operational management in the UK entity to strategic oversight at the Indian holding company level.
Dr. Vikash Agarwal ceased to hold the office of Chairperson at the close of business hours on August 3, 2026. He will continue to serve as the Managing Director of Crizac Limited, focusing on strategic management and executive responsibilities. His departure from the chairmanship is not a cessation of directorship but a realignment of roles to enhance operational efficiency. Similarly, Ms. Pinky Agarwal, a Non-Executive Non-Independent Director, tendered her resignation effective August 3, 2026. She confirmed there are no material reasons for her resignation other than pre-occupancies and professional commitments. Consequently, she also ceases to be a member of the Nomination & Remuneration Committee and the Risk Management Committee.
| Director | Action | Effective Date | New Role / Status |
|---|---|---|---|
| Christopher Flood Nagle | Appointment | August 3, 2026 | Additional Non-Executive Director |
| Christopher Flood Nagle | Appointment | August 4, 2026 | Chairperson of the Board |
| Dr. Vikash Agarwal | Resignation | August 3, 2026 | Ceases as Chairperson; continues as MD |
| Ms. Pinky Agarwal | Resignation | August 3, 2026 | Ceases as Director and Committee Member |
In addition to these changes, the Board has approved the re-appointment of two Independent Directors for a second term of three years, subject to shareholder approval at the ensuing 15th Annual General Meeting scheduled for September 11, 2026. Mr. Anuj Saraswat will serve from February 14, 2027, to February 13, 2030, while Ms. Payal Bafna’s term will run from March 21, 2027, to March 20, 2030. Both directors are not liable to retire by rotation.
Governance Restructuring
The Board has also reconstituted its key committees following the exit of Ms. Pinky Agarwal. The Nomination & Remuneration Committee now comprises Mr. Rakesh Kumar Agrawal (Chairman), Mr. Christopher Flood Nagle (Member), and Mr. Anuj Saraswat (Member). The Risk Management Committee has been reshuffled with Mr. Manish Agarwal assuming the role of Chairman, alongside members Mr. Vikash Agarwal and Mr. Anuj Saraswat. These adjustments ensure compliance with Section 178 of the Companies Act, 2013, and Regulations 19 and 21 of the SEBI LODR Regulations, maintaining robust oversight mechanisms during the leadership transition.
Historical Stock Returns for Crizac
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.38% | +6.93% | -6.35% | -20.15% | -52.96% | 0.0% |
How might the shift of Dr. Vikash Agarwal from Chairperson to Managing Director impact the balance between strategic oversight and day-to-day operational execution at Crizac?
What specific strategic initiatives is the new Chairperson, Christopher Flood Nagle, expected to prioritize given his transition from leading the UK subsidiary to overseeing the Indian holding company?
Will the reconstitution of the Nomination & Remuneration and Risk Management committees influence investor confidence or regulatory scrutiny during this leadership transition period?


































